BioSpace News Archive

Veterinary Orthopedics Treatment Market to Touch $153.61 Billion by 2025 at 6.2% CAGR

Ascend in creature medical services use and innovative improvements in therapeutics and analytic items are relied upon to help the development of the worldwide veterinary orthopedic treatment market

August 27, 2021
·
4 min read
Bowel Management Systems Market Size to Garner $3.59 Billion Growing at 4.5% CAGR Globally, by 2026

Increase in incidences of irritable bowel syndrome and growth in the geriatric population across the globe have boosted the growth of the global bowel management systems market.

August 27, 2021
·
4 min read
Cancer Diagnostics Market Worth $280.59 billion by 2028 | Abbott Laboratories, Becton, Dickinson and Company, Bio-Rad Laboratories

Increase in incidences and prevalence of various cancer types, initiatives by government and other organizations to spread awareness about cancer, and surge in number of diagnostics laboratories in developed countries drive the growth of the global cancer diagnostics market.

August 27, 2021
·
4 min read
Irritable Bowel Syndrome Treatment Market to Reach $2.01 Billion by 2026 at 8.2% CAGR

Expansion in geriatric populace, ascend in the pervasiveness of gastrointestinal problems, and flood in the quantity of pipeline drugs have supported the development of the worldwide touchy irritable bowel syndrome treatment market.

August 27, 2021
·
4 min read
Neurofibromatosis Type I Market to Record Significant Revenue Growth During the Forecast Period 2021-2028

A recent market research report added to repository of Credible Markets is an in-depth analysis of Neurofibromatosis Type I Market.

August 27, 2021
·
5 min read
Satellos Bioscience Announces High Resolution Crystal Structure of Duchenne Drug Target

Satellos Bioscience Inc. (TSXV: MSCL) (“Satellos”) announced today that they have successfully determined a high resolution (1.85Å) X-ray crystal structure of their novel drug target for Duchenne muscular dystrophy (“Duchenne”).

August 27, 2021
·
7 min read
Biotech Bay

Genentech Provides Update on Tecentriq U.S. Indication for PD-L1-Positive, Metastatic Triple-Negative Breast Cancer

Genentech, a member of the Roche Group (SIX: RO, ROG; OTCQX: RHHBY), today announced that the company has made the decision to voluntarily withdraw the U.S. accelerated approval for Tecentriq®.

August 27, 2021
·
14 min read
OrthoGrid Systems, Inc. Announces Launch of New OrthoGrid Hip Preservation Software Application for Peri Acetabular Osteotomy and Femoroplasty

OrthoGrid® Systems, Inc., a global medtech leader on a mission to digitally transform intraoperative musculoskeletal surgery, announces the launch of its new OrthoGrid Hip Preservation Application after receiving FDA clearance on February 18, 2021

August 27, 2021
·
3 min read
Immune Checkpoint Inhibitors Market Size to Reach $56.53 Billion & Growing at CAGR of 20.1% by 2025, with Increase in Awareness of Checkpoint Inhibitor Drugs in the Developing Countries.

Rise in prevalence of cancer worldwide, increase in demand for ideal therapeutics, positive outcome of checkpoint inhibitors in cancer treatment, favorable reimbursement policies in major countries, and technological advancements in screening & diagnosis of cancer are expected to boost the growth of the market.

August 27, 2021
·
5 min read
Neurodiagnostics Market to See Record Break Revenue $12.89 Billion By 2030, At CAGR Of 7.0% | AMR

Increase in innovations in neurodiagnostics products, and rise in number of product approvals are the other factors that contribute toward growth of the market

August 27, 2021
·
4 min read